350 related articles for article (PubMed ID: 25502425)
1. Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment.
Kurian AW; Kingham KE; Ford JM
Curr Opin Obstet Gynecol; 2015 Feb; 27(1):23-33. PubMed ID: 25502425
[TBL] [Abstract][Full Text] [Related]
2. Genetic risk assessment for breast and gynecological malignancies.
Profato JL; Arun BK
Curr Opin Obstet Gynecol; 2015 Feb; 27(1):1-5. PubMed ID: 25502427
[TBL] [Abstract][Full Text] [Related]
3. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
[TBL] [Abstract][Full Text] [Related]
4. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Tung N; Battelli C; Allen B; Kaldate R; Bhatnagar S; Bowles K; Timms K; Garber JE; Herold C; Ellisen L; Krejdovsky J; DeLeonardis K; Sedgwick K; Soltis K; Roa B; Wenstrup RJ; Hartman AR
Cancer; 2015 Jan; 121(1):25-33. PubMed ID: 25186627
[TBL] [Abstract][Full Text] [Related]
5. Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan.
Bando H
Breast Cancer; 2014 Nov; 21(6):656-63. PubMed ID: 23754181
[TBL] [Abstract][Full Text] [Related]
6. Hereditary gynecologic cancers: risk assessment, counseling, testing and management.
Ballinger LL
Obstet Gynecol Clin North Am; 2012 Jun; 39(2):165-81. PubMed ID: 22640709
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients.
Lincoln SE; Kobayashi Y; Anderson MJ; Yang S; Desmond AJ; Mills MA; Nilsen GB; Jacobs KB; Monzon FA; Kurian AW; Ford JM; Ellisen LW
J Mol Diagn; 2015 Sep; 17(5):533-44. PubMed ID: 26207792
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Utility of Next Generation Sequencing Results in a Community-Based Hereditary Cancer Risk Program.
Bunnell AE; Garby CA; Pearson EJ; Walker SA; Panos LE; Blum JL
J Genet Couns; 2017 Feb; 26(1):105-112. PubMed ID: 27276934
[TBL] [Abstract][Full Text] [Related]
9. Clinical management of patients at inherited risk for gynecologic cancer.
Powell CB
Curr Opin Obstet Gynecol; 2015 Feb; 27(1):14-22. PubMed ID: 25490378
[TBL] [Abstract][Full Text] [Related]
10. Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
Lerner-Ellis J; Khalouei S; Sopik V; Narod SA
Expert Rev Anticancer Ther; 2015; 15(11):1315-26. PubMed ID: 26523341
[TBL] [Abstract][Full Text] [Related]
11. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer: Genetics and Risk Assessment.
Tejada-Bergés T
Clin Obstet Gynecol; 2016 Dec; 59(4):673-687. PubMed ID: 27749364
[TBL] [Abstract][Full Text] [Related]
13. The role of genetic testing for cancer susceptibility in gynecologic practice.
Karlan BY; Berchuck A; Mutch D
Obstet Gynecol; 2007 Jul; 110(1):155-67. PubMed ID: 17601911
[TBL] [Abstract][Full Text] [Related]
14. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Chen LM; Richardson DL;
Gynecol Oncol; 2015 Jan; 136(1):3-7. PubMed ID: 25238946
[TBL] [Abstract][Full Text] [Related]
15. Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2.
Minion LE; Dolinsky JS; Chase DM; Dunlop CL; Chao EC; Monk BJ
Gynecol Oncol; 2015 Apr; 137(1):86-92. PubMed ID: 25622547
[TBL] [Abstract][Full Text] [Related]
16. Opportunities and challenges of next-generation DNA sequencing for breast units.
Pilgrim SM; Pain SJ; Tischkowitz MD
Br J Surg; 2014 Jul; 101(8):889-98. PubMed ID: 24676784
[TBL] [Abstract][Full Text] [Related]
17. Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing.
Hernan I; Borràs E; de Sousa Dias M; Gamundi MJ; Mañé B; Llort G; Agúndez JA; Blanca M; Carballo M
J Mol Diagn; 2012; 14(3):286-93. PubMed ID: 22426013
[TBL] [Abstract][Full Text] [Related]
18. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
Shulman LP
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
[TBL] [Abstract][Full Text] [Related]
19. Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer.
Ozcelik H; Shi X; Chang MC; Tram E; Vlasschaert M; Di Nicola N; Kiselova A; Yee D; Goldman A; Dowar M; Sukhu B; Kandel R; Siminovitch K
J Mol Diagn; 2012 Sep; 14(5):467-75. PubMed ID: 22874498
[TBL] [Abstract][Full Text] [Related]
20. USPSTF recommends BRCA testing in women based on familial history.
Dangi-Garimella S
Am J Manag Care; 2014 Mar; 20(5 Spec No.):E6. PubMed ID: 25618620
[No Abstract] [Full Text] [Related]
[Next] [New Search]
